Efavirenz significantly affects pharmacokinetic exposure of artemether-lumefantrine in HIV-infected Ugandan adults

被引：0
|
作者：
Byakika-Kibwika, P. [1 ]
机构：
[1] Makerere Univ, Infect Dis Inst, Kampala, Uganda
来源：
TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2012年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：40 / 41
页数：2
相关论文
共 50 条
  • [31] Pharmacokinetic properties of the antimalarial combination therapy artemether-lumefantrine in normal-weight, overweight and obese healthy male adults
    Sugiarto, Sri Riyati
    Page-Sharp, Madhu
    Drinkwater, Jocelyn J.
    Davis, Wendy A.
    Salman, Sam
    Davis, Timothy M. E.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 59 (01)
  • [32] Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects
    Calderon, Monica M.
    Penzak, Scott R.
    Pau, Alice K.
    Kumar, Parag
    McManus, Maryellen
    Alfaro, Raul M.
    Kovacs, Joseph A.
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (08) : 1036 - 1042
  • [33] Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda
    Kay, Katherine
    Goodwin, Justin
    Ehrlich, Hanna
    Ou, Joyce
    Freeman, Tracey
    Wang, Kaicheng
    Li, Fangyong
    Wade, Martina
    French, Jonathan
    Huang, Liusheng
    Aweeka, Francesca
    Mwebaza, Norah
    Kajubi, Richard
    Riggs, Matthew
    Ruiz-Garcia, Ana
    Parikh, Sunil
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (03) : 660 - 669
  • [34] The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients
    T. Kredo
    K. Mauff
    L. Workman
    J. S. Van der Walt
    L. Wiesner
    P. J. Smith
    G. Maartens
    K. Cohen
    K. I. Barnes
    BMC Infectious Diseases, 16
  • [35] The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients
    Kredo, T.
    Mauff, K.
    Workman, L.
    Van der Walt, J. S.
    Wiesner, L.
    Smith, P. J.
    Maartens, G.
    Cohen, K.
    Barnes, K. I.
    BMC INFECTIOUS DISEASES, 2016, 16
  • [36] Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults
    Kasirye, Ronnie P.
    Grosskurth, Heiner
    Munderi, Paula
    Levin, Jonathan
    Anywaine, Zacchaeus
    Nunn, Andrew
    Kamali, Anatoli
    Baisley, Kathy
    AIDS, 2017, 31 (04) : 577 - 582
  • [37] Steady-state Pharmacokinetic Comparison of Generic and Branded Formulations of Lamivudine, Stavudine, and Nevirapine in HIV-infected Ugandan Adults
    Byakika-Kibwika, P.
    Lamorde, M.
    Kalemeera, F.
    D'Avolio, A.
    Mauro, S.
    Di Perri, G.
    Ryan, M.
    Khoo, S.
    Boffito, M.
    Merry, C.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E199 - E199
  • [38] Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults
    Byakika-Kibwika, Pauline
    Lamorde, Mohammed
    Kalemeera, Francis
    D'Avolio, Antonio
    Mauro, Sciandra
    Di Perri, Giovanni
    Ryan, Mairin
    Mayanja-Kizza, Harriet
    Khoo, Saye
    Back, David
    Boffito, Marta
    Merry, Concepta
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) : 1113 - 1117
  • [39] Population Pharmacokinetic/Pharmacogenetic Model for Optimization of Efavirenz Therapy in Caucasian HIV-Infected Patients
    Sanchez, Almudena
    Cabrera, Salvador
    Santos, Dolores
    Paz Valverde, M.
    Fuertes, Aurelio
    Dominguez-Gil, Alfonso
    Garcia, Maria J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (11) : 5314 - 5324
  • [40] Profile of immunologic recovery in HIV-infected Ugandan adults after antiretroviral therapy
    Baker, Chris A. R.
    Emenyonu, Nneka
    Ssewanyana, Isaac
    Jones, Norman G.
    Elrefaei, Mohamed
    Nghania, Frehd
    Nakiwala, Justine
    Andia, Irene
    Clark, Richard
    Martin, Jeffrey
    Bangsberg, David R.
    Cao, Huyen
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (07) : 900 - 905
12345